Report an error
Spotted something inaccurate in “GLP-1 Receptor Agonists Associated With Reduced Fragility Fracture Risk in Diabetics”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.